These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 18585086
1. Neuromelanin-bound ferric iron as an experimental model of dopaminergic neurodegeneration in Parkinson's disease. Gerlach M, Riederer P, Double KL. Parkinsonism Relat Disord; 2008; 14 Suppl 2():S185-8. PubMed ID: 18585086 [Abstract] [Full Text] [Related]
3. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease. Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL. Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336 [Abstract] [Full Text] [Related]
4. Alpha-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates. Purisai MG, McCormack AL, Langston WJ, Johnston LC, Di Monte DA. Neurobiol Dis; 2005 Dec; 20(3):898-906. PubMed ID: 16006134 [Abstract] [Full Text] [Related]
5. Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration. Zhang X, Xie W, Qu S, Pan T, Wang X, Le W. Biochem Biophys Res Commun; 2005 Jul 29; 333(2):544-9. PubMed ID: 15950935 [Abstract] [Full Text] [Related]
6. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease. Lee FK, Wong AK, Lee YW, Wan OW, Chan HY, Chung KK. J Neurochem; 2009 Jul 29; 110(1):208-19. PubMed ID: 19457126 [Abstract] [Full Text] [Related]
8. Osteopontin is elevated in Parkinson's disease and its absence leads to reduced neurodegeneration in the MPTP model. Maetzler W, Berg D, Schalamberidze N, Melms A, Schott K, Mueller JC, Liaw L, Gasser T, Nitsch C. Neurobiol Dis; 2007 Mar 29; 25(3):473-82. PubMed ID: 17188882 [Abstract] [Full Text] [Related]
9. Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age. Kaur D, Peng J, Chinta SJ, Rajagopalan S, Di Monte DA, Cherny RA, Andersen JK. Neurobiol Aging; 2007 Jun 29; 28(6):907-13. PubMed ID: 16765489 [Abstract] [Full Text] [Related]
15. The relevance of iron in the pathogenesis of Parkinson's disease. Sian-Hülsmann J, Mandel S, Youdim MB, Riederer P. J Neurochem; 2011 Sep 29; 118(6):939-57. PubMed ID: 21138437 [Abstract] [Full Text] [Related]
18. Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression. Sedaghat K, Finkelstein DI, Gundlach AL. Brain Res; 2009 May 19; 1271():83-94. PubMed ID: 19328193 [Abstract] [Full Text] [Related]
19. Identification and kainic acid-induced up-regulation of low-affinity p75 neurotrophin receptor (p75NTR) in the nigral dopamine neurons of adult rats. Wang YQ, Bian GL, Bai Y, Cao R, Chen LW. Neurochem Int; 2008 Sep 19; 53(3-4):56-62. PubMed ID: 18639597 [Abstract] [Full Text] [Related]
20. Does cellular iron dysregulation play a causative role in Parkinson's disease? Kaur D, Andersen J. Ageing Res Rev; 2004 Jul 19; 3(3):327-43. PubMed ID: 15231240 [Abstract] [Full Text] [Related] Page: [Next] [New Search]